Skip to main content
. 2020 Jan 21;26:1076029619900549. doi: 10.1177/1076029619900549

Table 1.

Baseline Clinical Characteristics.a

Parameter Survived, n = 163 Died, n = 28 P Value
Age, years 59.5 (16.0) 62.3 (15.2) .42
Gender
 Male 83 (50.9%) 12 (42.9%) .43
 Female 80 (49.1%) 16 (57.1%)
CAD 16 (9.80%) 4 (14.3%) .51
CHF 20 (12.3%) 4 (14.3%) .79
DM 32 (19.6%) 6 (21.4%) .90
HTN 88 (54.0%) 16 (57.1%) .84
Chronic pulmonary disease (not asthma or COPD) 5 (3.10%) 5 (17.9%) <.01
COPD 10 (6.10%) 1 (3.60%) .57
Prior DVT 24 (14.7%) 7 (25.0%) .18
Prior PE 23 (14.1%) 8 (28.6%) .06
Prior stroke 11 (6.70%) 4 (14.3%) .18
PE severity
 Low risk 54 (33.1%) 7 (25.0%) .53
 Submassive 99 (60.7%) 18 (64.3%)
 Massive 10 (6.10%) 3 (10.7%)
Vitals
 SBP, mm Hg 106 (97.0-117) 101 (88.0-119) .17
 HR, beats/min 106 (20.9) 113 (30.0) .22
 RR, breaths/min 23.0 (20.0-27.0) 21.0 (18.0-30.0) .75
PESI score 90.0 (68.0-121) 123 (107-170) <.01
sPESI score 1.00 (0-2.00) 2.00 (1.25-3.75) <.01
WBC, K/µL 9.20 (7.10-11.2) 9.40 (5.60-10.9) .26
Neutrophil count, K/mm3 6.40 (5.00-8.40) 6.60 (4.10-9.20) .66
Lymphocyte count, K/mm3 1.50 (1.10-2.20) 0.800 (0.400-1.30) <.01
Hgb, g/dL 13.1 (11.5-14.7) 11.5 (9.83-13.5) <.01
Platelet count, K/µL 227 (175-284) 205 (126-272) .20

Abbreviations: CAD, coronary artery disease; CHF, congestive heart failure; DM, diabetes mellitus; HTN, hypertension; COPD, chronic obstructive pulmonary disease; DVT, deep venous thrombosis; Hgb, hemoglobin; HR, heart rate; IQR, interquartile range; PE, pulmonary embolism; PESI, Pulmonary Embolism Severity Index; RR, respiratory rate; SBP, systolic blood pressure; SD, standard deviation; sPESI, Simplified Pulmonary Embolism Severity Index; WBC, white blood cells.

a Values are expressed as mean (SD), median (IQR), and individuals (percentage).